FrancophonIA/ELRC3.0 huggingface dataset:
English: Zessly is an anti-inflammatory medicine for treating the following diseases:
Slovenian: Zessly je protivnetno zdravilo za zdravljenje naslednjih bolezni:
English: After each infusion, the patient should be monitored for 1 to 2 hours in case they have an allergic reaction, such as swelling of the mouth, face and throat, skin rash, and difficulty breathing.
Slovenian: Po vsaki infuziji je treba bolnika spremljati eno do dve uri, saj se lahko pri njem pojavi alergijska reakcija, kot je otekanje ust, obraza in grla, kožni izpuščaj in težave z dihanjem.
English: For some conditions, Zessly is also used in combination with another medicine, methotrexate.
Slovenian: Pri nekaterih boleznih se zdravilo Zessly uporablja tudi v kombinaciji z drugim zdravilom, metotreksatom.
English: Zessly must also not be used in patients with tuberculosis, other severe infections, or moderate or severe heart failure (an inability of the heart to pump enough blood around the body).
Slovenian: Ne sme se uporabljati pri bolnikih s tuberkulozo, drugimi hudimi okužbami ali zmernim do hudim srčnim popuščanjem (nezmožnostjo srca, da črpa dovolj krvi po telesu).
English: By attaching to TNF-α, infliximab blocks its activity and thereby reduces inflammation and other symptoms of the diseases.
Slovenian: Infliksimab z vezavo na TNF-α zavre njegovo delovanje ter tako zmanjša vnetja in druge simptome bolezni.
English: Side effects reported with Zessly are carefully evaluated and any necessary action taken to protect patients.
Slovenian: Neželeni učinki, o katerih so poročali pri zdravilu Zessly, se skrbno ovrednotijo in po potrebi se sprejmejo ukrepi za zaščito bolnikov.
English: To reduce the risk of infusion reactions, patients may be given other medicines before or during treatment with Zessly or the infusion may be slowed down.
Slovenian: Za zmanjšanje tveganja za pojav infuzijskih reakcij lahko bolniki pred zdravljenjem z zdravilom Zessly ali med njim prejemajo druga zdravila ali pa se hitrost infundiranja upočasni.
English: The European Medicines Agency decided that, in accordance with EU requirements for biosimilar medicines, Zessly has been shown overall to have a comparable quality, safety and effectiveness to Remicade.
Slovenian: Evropska agencija za zdravila je zaključila, da je bilo v skladu z zahtevami EU glede podobnih bioloških zdravil dokazano, da je zdravilo Zessly po kakovosti, varnosti in učinkovitosti primerljivo zdravilu Remicade.
English: The most common side effects with Zessly (seen in more than 1 patient in 10) are viral infections (such as flu and cold sores), headache, upper respiratory tract infection (nose and throat infection), sinusitis (inflammation of the sinuses), nausea (feeling sick), abdominal pain (stomach ache), infusionrelated reactions and pain.
Slovenian: Najpogostejši neželeni učinki zdravila Zessly (opaženi pri več kot 1 bolniku od 10) so virusne okužbe (na primer gripa ali herpes), glavobol, okužbe zgornjih dihal (okužbe nosu in žrela), sinusitis (vnetje sinusov), navzeja (slabost), bolečine v trebuhu, reakcije, povezane z infuzijo, in bolečine.
English: As for all medicines, data on the use of Zessly are continuously monitored.
Slovenian: Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Zessly stalno spremljajo.
English: The study looked at the proportion of patients who achieved at least a 20% reduction in ACR scores (a measure of painful, swollen joints and other symptoms) after 14 weeks of treatment.
Slovenian: V študiji so proučevali delež bolnikov, pri katerih je po 14 tednih zdravljenja prišlo do najmanj 20-odstotnega zmanjšanja rezultata ACR (merilo za boleče, otekle sklepe in druge simptome).
English: In addition, Zessly was as effective as Remicade in a study of 650 rheumatoid arthritis patients whose previous treatment with methotrexate alone had not worked well enough.
Slovenian: Poleg tega je bilo zdravilo Zessly v študiji pri 650 bolnikih z revmatoidnim artritisom, pri katerih predhodno zdravljenje s samim metotreksatom ni bilo dovolj uspešno, enako učinkovito kot zdravilo Remicade.
English: Zessly is given as an infusion (drip) into a vein over 2 hours.
Slovenian: Zdravilo Zessly se daje kot (kapalna) infuzija v veno, ki traja dve uri.
English: Other information about Zessly
Slovenian: Druge informacije o zdravilu Zessly
English: The active substance in Zessly, infliximab, is a monoclonal antibody (a type of protein) that attaches to a substance in the body called tumour necrosis factor alpha (TNF-α).
Slovenian: Učinkovina v zdravilu Zessly, infliksimab, je monoklonsko protitelo (vrsta beljakovine), ki se veže na snov, imenovano tumorje nekrotizirajoči faktor alfa (TNF-α).
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Zessly have also been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in previdnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Zessly upoštevati zdravstveni delavci in bolniki, so vključeni tudi v povzetek glavnih značilnosti zdravila in navodilo za uporabo.
English: In particular, information will be provided for doctors who intend to prescribe the medicine to children with Crohn's disease or ulcerative colitis, to explain that these patients may be at an increased risk of developing infections and to remind of the importance of keeping vaccinations up to date.
Slovenian: Zdravniki, ki nameravajo to zdravilo predpisovati otrokom s Crohnovo boleznijo ali ulceroznim kolitisom, bodo prejeli še posebne informacije, v katerih bo pojasnjeno, da pri teh bolnikih obstaja povečano tveganje za okužbe, opozorjeni pa bodo tudi na pomembnost rednega cepljenja.
English: The company that markets Zessly will provide an alert card for patients and educational material for prescribers, summarising the safety information about the medicine.
Slovenian: Družba, ki trži zdravilo Zessly, bo priskrbela opozorilno kartico za bolnike in izobraževalno gradivo za zdravnike, ki bodo to zdravilo predpisovali, v katerih bodo navedene informacije o varnosti zdravila.
English: Because Zessly is a biosimilar medicine, the studies on effectiveness and safety carried out with Remicade do not all need to be repeated for Zessly.
Slovenian: Zdravilo Zessly je podobno biološko zdravilo, zato vseh študij o učinkovitosti in varnosti, izvedenih z zdravilom Remicade, pri zdravilu Zessly ni treba ponavljati.
English: Zessly can only be obtained with a prescription and treatment should be started and supervised by a specialist doctor who has experience in the diagnosis and treatment of the diseases that Zessly is used to treat.
Slovenian: Predpisovanje in izdaja zdravila Zessly je le na recept, zdravljenje z njim pa lahko uvede in nadzoruje le zdravnik specialist, ki ima izkušnje z diagnosticiranjem in zdravljenjem bolezni, za katere se zdravilo Zessly uporablja.
English: This substance is involved in causing inflammation and is found at high levels in patients with the diseases that Zessly is used to treat.
Slovenian: Ta snov sodeluje pri nastanku vnetij in je v visokih koncentracijah prisotna pri bolnikih z boleznimi, za zdravljenje katerih se uporablja zdravilo Zessly.
English: Zessly must not be used in patients who are hypersensitive (allergic) to infliximab, mouse proteins or any of the other ingredients of Zessly.
Slovenian: Zdravila Zessly ne smejo jemati bolniki, ki so preobčutljivi za (alergični na) infliksimab, mišje beljakovine ali na katero koli drugo sestavino zdravila.
English: For more information about using Zessly, see the package leaflet or contact your doctor or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila Zessly glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.
English: • psoriasis (red, scaly patches on the skin)
Slovenian: • psoriaze (rdečih, luskastih zaplat na koži);
English: • Crohn's disease (disease causing inflammation of the gut)
Slovenian: • Crohnove bolezni (bolezni, ki povzroča vnetje črevesa);
English: The dose of Zessly and how often it is given depends on the patient's body weight and the condition being treated.
Slovenian: Odmerek zdravila Zessly in pogostnost dajanja sta odvisna od bolnikove telesne mase in zdravljene bolezni.
English: • ankylosing spondylitis (inflammation of spine causing back pain)
Slovenian: • ankilozirajočega spondilitisa (vnetja hrbtenice, ki povzroča bolečine v hrbtu);
English: Laboratory studies comparing Zessly with Remicade have shown that the active substance in Zessly is highly similar to that in Remicade in terms of structure, purity and biological activity.
Slovenian: Laboratorijske študije, v katerih so zdravilo Zessly primerjali z zdravilom Remicade, so pokazale, da je učinkovina v zdravilu Zessly po zgradbi, čistosti in biološkem delovanju zelo podobna učinkovini v zdravilu Remicade.
English: • psoriatic arthritis (psoriasis with inflammation of the joints).
Slovenian: • psoriatičnega artritisa (psoriaze z vnetjem sklepov).
English: Studies have also shown that giving Zessly produces similar levels of the active substance in the body to giving Remicade.
Slovenian: Študije so pokazale tudi, da zdravilo Zessly vzpostavi podobne ravni učinkovine v telesu kot zdravilo Remicade.
English: How is Zessly used?
Slovenian: Kako se zdravilo Zessly uporablja?
English: • ulcerative colitis (inflammation and ulcers in the lining of the gut)
Slovenian: • ulceroznega kolitisa (vnetja in razjed v črevesni sluznici);
English: Therefore, the Agency's view was that, as for Remicade, the benefit of Zessly outweighs the identified risk and it can be authorised.
Slovenian: Menila je, da koristi zdravila Zessly enako kot pri zdravilu Remicade odtehtajo znana tveganja in da se zdravilo lahko odobri.
English: The reference medicine for Zessly is Remicade.
Slovenian: Referenčno zdravilo za zdravilo Zessly je zdravilo Remicade.
English: Zessly is a ‘biosimilar medicine'.
Slovenian: Zdravilo Zessly je „podobno biološko zdravilo“.
English: For the full list of side effects of Zessly, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Zessly, glejte navodilo za uporabo.
English: • rheumatoid arthritis (disease causing inflammation of the joints)
Slovenian: • revmatoidnega artritisa (bolezni, ki povzroča vnetje sklepov);
English: How does Zessly work?
Slovenian: Kako zdravilo Zessly deluje?
English: Bratislava, Slovakia.
Slovenian: Bratislava, Slovaška.
English: 152 32 Halandri, Athens
Slovenian: 152 32 Halandri, Atene
English: 170 09 Sverige (SWE)
Slovenian: 170 09 Sverige (SWE) Švedska
English: Meda AS Solvang 8
Slovenian: Danska Meda AS Solvang 8
English: Bruninieku 5, Riga, LV1001, Latvia
Slovenian: Bruninieku 5, Riga, LV1001, Latvija
English: A-1140 Wien
Slovenian: A-1140 Dunaj
English: A. Goštauto g. 40A LT-01112 Vilnius, Lithuania
Slovenian: A. Goštauto g. 40A LT-01112 Vilnius, Litva
English: Valeas S.p.A. via Vallisneri 10 20133 Milano
Slovenian: via Vallisneri 10 20133 Milano
English: Slovak Republic GlaxoSmithKline Slovakia sro., Galvaniho7/A, 82104
Slovenian: Slovaška GlaxoSmithKline Slovakia sro., Galvaniho7/A, 82104
English: 28760 Tres Cantos (Madrid).
Slovenian: 28760 Tres Cantos
English: GlaxoSmithKline 100, route de Versailles78163 Marly-le-Roi Cedex
Slovenian: Francija Laboratoire GlaxoSmithKline 100, route de Versailles78163 Marly-le-Roi Cedex
English: GlaxoSmithKline Pharma GmbH, Albert SchweitzerGasse 6,
Slovenian: Avstrija GlaxoSmithKline Pharma GmbH, Albert SchweitzerGasse 6,
English: GlaxoSmithKline Latvia SIA
Slovenian: Latvija GlaxoSmithKline Latvia SIA
English: GlaxoSmithKlineProdutos Farmacêuticos, Lda.)
Slovenian: GlaxoSmithKline - Produtos Farmacêuticos, Lda.)
English: United Kingdom Beecham Group PLC SB House
Slovenian: Beecham Group PLC SB House
English: GlaxoSmithKline Export Ltd
Slovenian: Poljska GlaxoSmithKline Export Ltd
English: GSK d.o.o., Ljubljana Knezov štradon 90 SI-1000 Ljubljana Slovenija
Slovenian: Slovenija GSK d.o.o., Ljubljana Knezov štradon 90
English: Bial - Portela & Cª, S.A À Av. da Siderurgia Nacional - 4745-457 S. Mamede do Coronado Portugal
Slovenian: Bial - Portela & Cª, S.A À Av. da Siderurgia Nacional - 4745-457 S. Mamede do Coronado Portugalska
English: Glaxo Smith Kline B.V. Huis ter Heideweg 62 3705 LZ ZEIST THE NETHERLANDS
Slovenian: Huis ter Heideweg 62 3705 LZ ZEIST NIZOZEMSKA
English: À Av. da Siderurgia Nacional - 4745-457 S. Mamede do Coronado Portugal
Slovenian: À Av. da Siderurgia Nacional - 4745-457 S. Mamede do Coronado Portugalska
English: 1000mg : 200mg/ 20.9ml or 120ml
Slovenian: 1000 mg : 200 mg/ 20,9 ml ali 120 ml
English: GlaxoSmithKline ehf.
Slovenian: Islandija GlaxoSmithKline ehf.
English: Laboratórios BIAL À Av. da Siderurgia Nacional - 4745-457 S. Mamede do Coronado Portugal
Slovenian: Laboratórios BIAL À Av. da Siderurgia Nacional - 4745-457 S. Mamede do Coronado Portugalska
English: Augmentin Intravenous 600mg & 1.2gm
Slovenian: Augmentin Intravenous 600 mg & 1,2 mg
English: Waterford Road Clonmel
Slovenian: Clonmel Healthcare Limited Waterford Road Clonmel
English: SmithKline Beecham plc.
Slovenian: Estonija SmithKline Beecham plc.
English: Dispersible tablets Oral use
Slovenian: Disperzibilna tableta Peroralna uporaba
English: Rua Dr. António Loureiro Borges, 3
Slovenian: GlaxoSmithKline - Produtos Farmacêuticos Lda Rua Dr. António Loureiro Borges, 3
English: Augmentin 500/125mg FilmCoated Tablets
Slovenian: Augmentin 500/125 mg Film-Coated Tablets
English: Augmentin Augmentin 0,6 g prašek za raztopino za injiciranje ali infundiranje
Slovenian: Augmentin 0,6 g prašek za raztopino za injiciranje ali infundiranje
English: P.T.M.- C/Severo Ochoa, 2 28760 Tres Cantos (Madrid).
Slovenian: Laboratorios Beecham, S.A. P.T.M.- C/Severo Ochoa, 2 28760 Tres Cantos (Madrid).
English: GlaxoSmithKline GmbH & Co. KG
Slovenian: Nemčija GlaxoSmithKline GmbH & Co.
English: Intravenous 500mg/100mg Powder for Solution for Injection or Infusion
Slovenian: 500 mg/100 mg Powder for Solution for Injection or Infusion
English: Box 906
Slovenian: Švedska Meda AB Box 906
English: GlaxoSmithKline EOOD Ivan Vasov Complex Dimitar Manov street,
Slovenian: Bolgarija GlaxoSmithKline EOOD Ivan Vasov Complex Dimitar Manov street, bl.10, 1408 Sofija, Bolgarija
English: Clavamox 312,5 mg/5 mlTrockensaft
Slovenian: Clavamox 312,5 mg/5 ml - Trockensaft
English: 500mg : 50mg/ vial
Slovenian: 500 mg : 50 mg/ vialo
English: Middlesex TW8 9GS United Kingdom
Slovenian: Middlesex TW8 9GS Velika Britanija
English: 125/31.25mg/ 5mlOral suspension Oral use
Slovenian: 125/31,25 mg/ 5 ml Peroralna suspenzija Peroralna uporaba
English: 1000/200 mg Powder for solution for injection or infusion
Slovenian: 1000 mg/200 mg Powder for Solution for Injection or Infusion
English: Clavamox intravenös 550 mgTrockenstechampullen
Slovenian: Clavamox intravenös 550 mg
English: 1000mg : 100mg/ vial
Slovenian: 1000 mg : 100 mg/ vialo
English: Clavamel 125mg/31.25mg Paediatric Powder for Oral Suspension
Slovenian: 125 mg/31,25 mg Paediatric Powder for Oral Suspension
English: Augmentin 1 g Tablets
Slovenian: Augmentin 1 gFilmtabletten
English: AND Powder and solvent for solution for injection
Slovenian: IN Prašek in vehikel za raztopino za injiciranje
English: Clavamox intravenös 2,2 gTrockensubstanz zur Infusionsbereitung
Slovenian: Clavamox intravenös 2,2 g - Trockensubstanz zur Infusionsbereitung
English: Augmentin intravenös 1,1 gTrockensubstanz zur Infusionsbereitung
Slovenian: Augmentin intravenös 1,1 g - Trockensubstanz zur Infusionsbereitung
English: 2000mg : 200mg/ vial
Slovenian: 2000 mg : 200 mg/ vialo
English: Augmentin intravenös 2,2 gTrockensubstanz zur Infusionsbereitung
Slovenian: Augmentin intravenös 2,2 g - Trockensubstanz zur Infusionsbereitung
English: Powder for injection
Slovenian: Prašek za raztopino za injiciranje
English: Clavamox intravenös 1,1 gTrockensubstanz zur Infusionsbereitung
Slovenian: Clavamox intravenös 1,1 g - Trockensubstanz zur Infusionsbereitung
English: 980 Great West Road Brentford, Middlesex, TW8
Slovenian: 980 Great West Road Brentford, Middlesex, TW8 9GS
English: Luxembourg GlaxoSmithKline s.a. / n.v. Rue du Tilleul 13
Slovenian: Luksemburg GlaxoSmithKline s.a. / n.v.
English: Augmentin (80 /11.97 mg/ml) 400/57mg/ 5ml Powder for oral suspension
Slovenian: Augmentin (80 /11,97 mg/ml)
English: 875mg/125mg Film Coated Tablets
Slovenian: Augmentin 875 mg/125 mg Film Coated Tablets
English: Augmentin 1 g - Filmtabletten 875/125 mg
Slovenian: Augmentin 1 g Tablets 875/125 mg
English: 500mg : 100mg/ 10.5ml or 60 ml
Slovenian: 500 mg : 100 mg/ 10,5 ml ali 60 ml
English: Augmentin 875/125mg tablets 875/125 mg
Slovenian: Augmentin 875/125 mg tablets
English: Augmentin 250/125mg
Slovenian: Augmentin 250/125 mg 250/125 mg
English: 500mg / 50mg/ 10.5ml or 25ml
Slovenian: 500 mg / 50 mg/ 10,5 ml ali 25 ml
English: 250/62.5mg/ 5 ml
Slovenian: 250/62,5 mg/ 5 ml (Amoxicillin:
English: Middlesex TW8 9GS UK
Slovenian: Middlesex TW8 9GS VB
English: Augmentin intravenös 550 mg - Trockenstechampullen
Slovenian: Augmentin intravenös 550 mg
English: Belgium GlaxoSmithKline s.a. / n.v. Rue du Tilleul 13
Slovenian: Belgija GlaxoSmithKline s.a. / n.v.
English: 500mg : 50mg/ 10.5ml or 25ml
Slovenian: 500 mg : 50 mg/ 10,5 ml ali 25 ml
English: Clavamox 625 mg - lösliche Tabletten
Slovenian: Clavamox 625 mglösliche Tabletten
English: Great West Road
Slovenian: Great West Road Brentford
English: 125/31.25 mg/ 5 ml
Slovenian: 125/31,25 mg/ 5 ml (Amoxicillin 25 mg/ml)
English: Powder for injection or infusion
Slovenian: Prašek za injiciranje ali infundiranje
English: Augmentin 156 mg/5 ml
Slovenian: Augmentin 312 mg/5 ml 250/62,5 mg/ 5 ml
English: Augmentin Intravenous 600mg 500/100 mg
Slovenian: Augmentine Intravenoso 500/50 mg
English: Augmentin 125/31 SF Sachet 125/31.25mg Powder for oral suspension
Slovenian: Augmentin 156 mg/5 ml 125/31,25 mg / 5 ml Prašek za peroralno suspenzijo
English: Augmentin 625 mg - lösliche Tabletten
Slovenian: Augmentin 625 mg Tablets
English: 400/57mg/ 5ml (Amoxicillin: 80 mg/ml)
Slovenian: 400/57 mg/ 5 ml (Amoxicillin:
English: Beecham Group plc 980 Great West Road, Brentford, Middlesex TW8 9GS
Slovenian: Romunija Beecham Group PLC 980 Great West Road, Brentford, Middlesex TW8 9GS
English: 400/57mg/ 5 ml
Slovenian: Augmentin DUO 400/57 mg/ 5 ml
English: Augmentine Intravenoso
Slovenian: Intravenous
English: This summary was last updated: 19/11/2010
Slovenian: Povzetek je bil nazadnje posodobljen 19/11/2010.
English: These side effects occur generally within the first week of treatment and are usually temporary and disappear once treatment has stopped.
Slovenian: Ti neželeni učinki se običajno pojavijo v prvem tednu zdravljenja in so navadno prehodni ter po končanem zdravljenju minejo.
English: Other information about Meloxoral:
Slovenian: Druge informacije o zdravilu Meloxoral:
English: It can be used for both acute disorders, such as those seen after an injury, and chronic (long term) disorders.
Slovenian: Lahko se uporablja za akutna obolenja, do katerih pride ob poškodbi, in tudi za kronična (dolgotrajna) obolenja.
English: If the product is swallowed by a person, the advice of a doctor should be sought immediately.
Slovenian: Če oseba zaužije zdravilo, se je treba nemudoma posvetovati z zdravnikom.
English: Meloxoral contains the active substance meloxicam in a strength of 0.5 mg/ml (cats) or 1.5 mg/ml (dogs) for the oral suspension.
Slovenian: Zdravilo Meloxoral vsebuje zdravilno učinkovino meloksikam v jakosti 0,5 mg/ml (mačke) ali 1,5 mg/ml (psi) v peroralni suspenziji.
English: People who are hypersensitive (allergic) to NSAIDs should avoid contact with Meloxoral.
Slovenian: Osebe, ki so preobčutljive za (alergične na) nesteroidna protivnetna zdravila, naj se izogibajo stiku z zdravilom Meloxoral.
English: Studies looked at how Meloxoral was absorbed and its effects in the body, in comparison with Metacam.
Slovenian: V študijah so proučevali absorbiranje zdravila Meloxoral in njegove učinke na telo v primerjavi z zdravilom Metacam.
English: Meloxoral contains meloxicam, which belongs to a class of medicines called non-steroidal antiinflammatory drugs (NSAIDs).
Slovenian: Zdravilo Meloxoral vsebuje meloksikam, ki spada v skupino zdravil, imenovanih nesteroidna protivnetna zdravila (NSAID).
English: The Committee for Medicinal Products for Veterinary Use (CVMP) considered that, in accordance with European Union requirements, Meloxoral has been shown to be bioequivalent to Metacam.
Slovenian: Odbor za zdravila za uporabo v veterinarski medicini (CVMP) je menil, da se je zdravilo Meloxoral v skladu z zahtevami Evropske unije izkazalo biološko enakovredno zdravilu Metacam.
English: Meloxoral is a ‘generic' which means that Meloxoral is similar to a ‘reference veterinary medicine' already authorised in the EU (Metacam).
Slovenian: Zdravilo Meloxoral je generično zdravilo, kar pomeni, da je podobno referenčnemu veterinarskemu zdravilu, ki je že odobreno v EU (zdravilu Metacam).
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Meloxoral to LeVet B.V. on 19/11/2010.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Meloxoral, veljavno po vsej Evropski uniji, odobrila družbi LeVet B.V.
English: prostaglandins are substances that trigger inflammation, pain, exudation and fever, meloxicam reduces those responses.
Slovenian: Prostaglandini so snovi, ki povzročajo vnetje, bolečino, izločanje tekočine in zvišano telesno temperaturo, meloksikam pa zmanjšuje obseg teh odzivov.
English: Why has Meloxoral been approved?
Slovenian: Zakaj je bilo zdravilo Meloxoral odobreno?
English: Occasional side effects of Meloxoral are those seen with NSAIDs, such as loss of appetite, vomiting, diarrhoea, blood appearing in the stools, renal failure and apathy (lack of vitality).
Slovenian: Občasni neželeni učinki zdravila Meloxoral so enaki kot pri drugih nesteroidnih protivnetnih zdravilih in obsegajo izgubo teka, bruhanje, drisko, kri v blatu, odpoved ledvic in apatijo (pomanjkanje vitalnosti).
English: Meloxoral is presented as a pale yellow oral suspension which is to be given mixed with food or directly into the mouth in dogs or cats.
Slovenian: Zdravilo Meloxoral je na voljo v obliki bledo rumene peroralne suspenzije, ki se psom ali mačkam daje pomešana s hrano ali neposredno v gobec.
English: How has the effectiveness of Meloxoral been studied?
Slovenian: Kako je bila raziskana učinkovitost zdravila Meloxoral?
English: Therefore the CVMP's view was that, as for Metacam, Meloxoral's benefits are greater than its risks to alleviate inflammation and pain in musculo-skeletal disorders and they recommended that Meloxoral should be given a marketing authorisation.
Slovenian: CVMP je zato menil, da so koristi zdravila Meloxoral pri umirjanju vnetja in lajšanju bolečine pri kostno-mišičnih obolenjih, tako kot pri zdravilu Metacam, večje od z njim povezanih tveganj, in priporočil, da se zanj odobri dovoljenje za promet.
English: Studies have been carried out to prove that Meloxoral is ‘bioequivalent' to the reference veterinary medicine which means that Meloxoral is equivalent to Metacam in the way it is absorbed and used by the body.
Slovenian: Za dokazovanje biološke enakovrednosti zdravila Meloxoral z referenčnim veterinarskim zdravilom so bile izvedene ustrezne študije, ki so pokazale, da je zdravilo Meloxoral enakovredno zdravilu Metacam glede na to, kako ga telo absorbira in uporablja.
English: Meloxicam acts by inhibition of prostaglandin synthesis.
Slovenian: Meloksikam učinkuje tako, da zavira tvorbo prostaglandinov.
English: What is Meloxoral used for?
Slovenian: Za kaj se zdravilo Meloxoral uporablja?
English: Meloxoral is used in dogs to relieve inflammation and pain in musculo-skeletal disorders.
Slovenian: Zdravilo Meloxoral se pri psih uporablja za lajšanje vnetja in bolečine pri kostno-mišičnih obolenjih.
English: In the case of accidental ingestion medical advice should be sought immediately, showing the package leaflet or label to the physician.
Slovenian: V primeru nenamernega zaužitja se takoj posvetujte z zdravnikom in mu pokažite navodilo za uporabo ali ovojnino.